Caas Capital Management LP Sarepta Therapeutics, Inc. Call Options Transaction History

Caas Capital Management LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $1.83 Million - $2.62 Million	-29,000 Reduced 40.28%	43,000 $3.36 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $3.42 Million - $4.28 Million	-49,300 Reduced 40.64%	72,000 $5.6 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $15.2 Million - $21.7 Million	121,300 New	121,300 $20.7 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.